News

IMGENEX India Pvt. Ltd. and RMRC, Bhubaneswar announces approval of Rapid Antigen Test (RAT) kits by Indian Council of Medical Research  

Bhubaneswar, January 28, 2022

COVID-19 pandemic has resulted in world-wide economic and social havoc. IMGENEX India is proud to announce that it has developed a RAT kit in collaboration with RMRC, Bhubaneswar. Based on the internal validation by RMRC, Bhubaneswar the report was submitted to the ICMR Central Office in New Delhi, who sent the kit to a third-party testing center. Based on the third-party testing report, ICMR approved our kit on January 27, 2022. This high sensitivity kit can detect all variants of Covid-19. This is the first RAT kit developed bya company in Odisha and Eastern Zone of India.

IMGENEX INDIA Pvt. Ltd., is one of the foremost biotechnology companies in the Eastern region of India and was founded in the year 2004 at Bhubaneswar. The R&D Unit of IMGENEX India possesses all the modern equipment for molecular biology, recombinant protein production, cell culture, antibody development and other downstream processes. The R&D unit of IMGENEX India was inaugurated in 2005 by Dr. APJ Abdul Kalam, the then Hon’ble President of India and is recognized by DSIR (Department of Scientific and Industrial Research), Ministry of Science & Technology, Govt. of India. 

RMRC, Bhubaneswar: 

CONTACT: